Filing Details

Accession Number:
0001181431-12-016128
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2012-03-09 19:02:07
Reporting Period:
2011-08-22
Filing Date:
2012-03-09
Accepted Time:
2012-03-09 19:02:07
Original Submission Date:
2011-09-30
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1425205 Genesis Biopharma Inc GNBP.OB Arrangement Of Transportation Of Freight & Cargo (4731) 753254381
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1412295 Martin Schroeder Emmes Group Consulting Llc
92 Natoma Street., #200
San Francisco CA 94105
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-08-22 1,000,000 $0.00 1,000,000 No 4 P Indirect See footnote.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect See footnote.
Footnotes
  1. Mr. Schroeder is Executive Vice President and Managing Director of Emmes Group Consulting LLC.